Skip to main content
Back to Database
Epinephrine Access Insurance · Cost SharingPendingFederal Checked 8/9/2026 Official Source

EPIPEN Act (Epinephrine Injector Price Reduction)

United States H.R. 5139 (119th Congress) 2025
DF
Primary Sponsor
Rep. Doris Matsui (CA-07) and Rep. Maxwell Alejandro Frost (FL-10)
Bipartisan · United States
EpinephrineFederalCostInsurancePending2025Bipartisan

Transparency & Verification

Verified from Official Source
Source AgencyNot specified
Last Updated2026-08-09
Last Verified2026-08-09
Verified ByPolicyPantry Editorial Team
Official Source URL https://www.congress.gov/bill/119th-congress/house-bill/5139 Link Unconfirmed — this source may not match this law (Blocked)

Turn this bill into a campaign your supporters can send to their legislators.

Last checked: 2026-09-25 approved

Policy Pantry collects information from official and trusted public sources. Legislative information can change quickly. Always review the linked official government source for the most current details.

AI Plain-Language Summary

Click "Generate" to create an AI-powered plain-language summary of this legislation.

Summary

Federal bill to cap the cost of life-saving epinephrine injectors by establishing cost-sharing requirements under group health plans and health insurance coverage.

Full Description

H.R. 5139, the EPIPEN Act, was reintroduced in the 119th Congress by Congresswoman Doris Matsui (CA-07) and Congressman Maxwell Alejandro Frost (FL-10). The bill establishes requirements with respect to cost sharing for epinephrine injectors under group health plans and group and individual health insurance coverage, aiming to cap out-of-pocket costs for this life-saving medication. This is an expanded version of legislation originally introduced in the 118th Congress as H.R. 6965.

Key Provisions

Caps cost sharing for epinephrine injectors under group health plans; applies to group and individual health insurance coverage; aims to make epinephrine auto-injectors affordable for all patients who need them.

Who This Bill Serves & Who's Backing It

Core Patient Populations

[object Object] Epinephrine AccessEpinephrineFederalCostInsurancePending2025Bipartisan

Patients who rely on timely access to emergency epinephrine.

Advocacy Groups Backing This Legislation

No advocacy organizations are currently tracked as backing this bill.Browse advocacy organizations →

Legislative Timeline

Legislative Session119th Congress (2025-2026)
CommitteeHouse Energy and Commerce

Votes & Legislative History

Legislative History & Resources

Take Action on This Law

Send a letter or generate testimony about this legislation.

Advocate Connect

See who's supporting this law, find advocates with shared goals, and combine advocacy efforts and letters to amplify your impact.

Log in to join as an advocate and connect with others supporting this law.

Be the first advocate to support this law and invite others to combine efforts.

Signed Into Law
Epinephrine AccessEnacted
Signed into Law
Verified Checked 9/25/2026 Link Unconfirmed Education

Self-administration of inhaled asthma or anaphylaxis medication – School board epinephrine injector policy

Mandates school boards to adopt policies permitting student self-administration of asthma and anaphylaxis medication and allows districts to stock epinephrine.

OK 70-1-116.3 2008
Trusted Reference
Trusted Reference Verified 2026-09-25
Alpha-gal SyndromeProposed
Introduced
Verified Checked 9/25/2026 Link Unconfirmed Food Safety

Alpha-Gal Allergen Inclusion Act

Alpha-Gal Allergen Inclusion Act

Adds alpha-gal to the federal list of major food allergens, requiring clear and specific labeling on all U.S. packaged food products to help Americans with AGS identify products that could trigger a life-threatening allergic reaction.

Warner, Mark R.
SponsorSen. Mark R. Warner (D-VA) (Bipartisan)
US S. [pending] (119th Congress)
alpha_galfood_labelingFALCPA+5
Official Government Source
Official Government Source Verified 2026-09-25
Alpha-gal SyndromeProposed
Introduced
Verified Checked 9/25/2026 Link Unconfirmed Healthcare

STOP TICKS Act

STOP TICKS Act (Strengthening Tick-borne disease Opposition and Prevention Through Investment in Collaboration, Knowledge, and Surveillance Act)

Reauthorizes and expands the federal Tick-Borne Disease Working Group (TBDWG) and increases CDC grant funding for states and researchers combating vector-borne diseases including alpha-gal syndrome.

Warner, Mark R.
SponsorSen. Mark R. Warner (D-VA) (Democratic)
US S. [pending] (119th Congress)
alpha_galtick_borne_diseaseCDC+3
Official Government Source
Official Government Source Verified 2026-09-25

While we strive for accuracy, information may change over time. Always double-check and verify against official sources before relying on it.

PolicyPantry

Connecting America to Allergy Knowledge, Laws, and Care.

Empowering advocates for allergy, asthma & anaphylaxis rights nationwide.

Follow @policypantry

Educational Disclaimer: The information on this platform is provided for general educational and informational purposes only. It is not medical advice and does not replace professional medical consultation, diagnosis, or treatment. Always seek the guidance of a qualified healthcare professional with any questions about a medical condition. If you are experiencing a medical emergency, call 911 immediately. While we strive for accuracy, please double-check and verify any information found here against official sources before relying on it.

Policy Pantry™ is a health policy technology platform empowering communities through legislation, advocacy, and innovation.

© 2026 Policy Pantry LLC. All Rights Reserved.